SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLDX Celldex Therapeudics -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (27)11/27/2019 9:48:44 AM
From: scaram(o)uche  Respond to of 105
 
0159 was derived from the Kolltan molecule, 0158, which exhibited pronounced injection site reactions in phase I testing. As of 12/31/18, the Kolltan potential contingency had dropped to $13.8m from the year earlier 43.4m.